New Delhi: ‘Shark Tank India 3’ has been creating headlines everyday with interesting pitches by entrepreneurs and creative nichs ideas that look at disrupting sectors everywhere. As sharks continue to invest in such deals, a joint deal in a chemotherapy relief solution by ‘Eva Scalp Cooling System’ has caught everyone’s attention.
In the most recent episode of “Shark Tank India,” season three, sharks Namita Thapar, Aman Gupta, and Ritesh Agarwal worked together to close a joint deal for “Eva Scalp Cooling System,” a chemotherapy comfort treatment, for Rs 30 lakh.
India’s first scalp cooling device for cancer treatment has been created by Raghuveer Surupa’s company, Stemtech Medical Devices, in a country that values innovation in medical technology.
Bringing his brainchild to the entrepreneurial reality show, Raghuveer, who is an IIM Ranchi alumnus, pitched a deal Rs 30 lakh for a two per cent equity stake.
At the head of Stemtech, Raghuveer is driving the organization with a vision shaped by his own experience of seeing his aunt fight valiantly against ovarian cancer.
The “Eva Scalp Cooling System,” a flagship product from Stemtech that is highly recommended by oncologists, assists cancer patients in avoiding hair loss, one of the most difficult side effects of chemotherapy.
This innovative system, installed in 12 hospitals across five states, has already conducted 1000 successful sessions in the past year.
The deal closed with Namita, the Executive Director of Emcure Pharmaceutical Ltd, Aman, co-founder and CMO, BOAT, and Ritesh, founder and CEO of OYO Rooms, at Rs 30 lakh for 1.8 per cent equity.
Discussing his experience on the show, Raghuveer said: “Shark Tank opportunity came at a very opportune moment for ‘Eva Scalp Cooling’. We have designed, developed and manufactured this device over the last four years. This show will give us the opportunity to raise awareness around the severity of hair loss caused by cancer treatment and the solution we provide.”
‘Shark Tank India 3’ airs on Sony LIV.
( with inputs from IANS)